Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Heplisav-B
Pharma
FDA approves VBI's PreHevbrio just as HBV market is set to grow
With an FDA approval for its hepatitis B shot, PreHevbrio, VBI Vaccines is poised to take advantage of what figures to be a growing market.
Kevin Dunleavy
Dec 1, 2021 10:34am
Efficacy, convenient dosage give Dynavax's Heplisav-B an edge
Nov 5, 2021 7:00am
Heplisav-B; Janssen and more—News of Note
Feb 27, 2019 9:14am
Dynavax, Emergent and more—News of Note
Aug 8, 2018 7:59am
FluMist, Heplisav-B and more—News of Note
Feb 21, 2018 8:46am
Dynavax secures $175M for Heplisav-B marketing, I-O studies
Feb 20, 2018 10:08am
